The Council of University Heads of Pharmacy Schools - CUHOP
   
 
 
Council of University Heads of Pharmacy : response to withdrawal of funding for equivalent or lower qualifications (ELQs)

Consultation question 1: Have we responded appropriately to the Government's instruction that certain categories of student should be exempt in the light of the Student Fees (Qualifying Courses and Persons) (England) Regulations and Education (Student Support) Regulations?


The Council of University Heads of Pharmacy proposes that pharmacy must be included in the list of exempt subjects. It appears anomalous that it was omitted from the original Student Fees (Qualifying Courses and Persons) (England) Regulations and Education (Student Support) Regulations).

  • Pharmacy is a vocational healthcare profession and should be treated no differently from all other medical, dental and allied health professions.
  • Pharmacists are on the UK Skills Shortage Occupations List.
  • The shortage of pharmacists is recognised elsewhere - in a 2006 survey 6.5% of junior pharmacist posts in the NHS were vacant (www.nhspedc.nhs.uk/pdf/Report%202006.pdf).
  • The 4-year undergraduate Master of Pharmacy degree qualification, followed by 1-year's pre-registration training, is the only route to registering with the regulator for pharmacy, the Royal Pharmaceutical Society of Great Britain.
  • Greater than 95% of students reading for the MPharm qualification proceed to register and practise as pharmacists (Willis et al. Pharm J. 2006:277,137-138.)
  • Workforce modelling commissioned by the Royal Pharmaceutical Society, in partnership with the Department of Health and the Welsh Assembly Government indicates that over the next 10 years pharmacist numbers will need to grow by 5% per annum. Even with greater efforts to increase retention and participation rates in employment a significant increase in the volume of the training pipeline is indicated.
  • This increased demand for new pharmacy undergraduates combined with the 18 - 30 year old demographic profile between 2006/7 and 2026/27 means that demand for pharmacy undergraduates will exceed supply in the traditional recruitment pools. The inability of graduates to re-train as pharmacists will place a serious constraint on healthworker development across the NHS and run counter to the government's goal of getting patient care closer to patients.
  • If workforce demand is to be met substantially by new graduates (in addition to retention and increasing participation rates) then pharmacy will need to look to non-traditional recruitment pools to meet employer-led demand - any barriers to for example graduates re-training as pharmacists will place a serious constraint on development of the pharmacy workforce and more generally across the NHS and run counter to the government's goal of getting patient care closer to patients.
  • Students highlighted as ELQ in the schools of pharmacy have 'first' qualifications in the pharmaceutical area, but as stated above the MPharm is the only vocational qualification leading to registration as a pharmacist. First degrees in chemistry, medicinal or pharmaceutical chemistry, pharmacology or related biomedical science predominate.
  • The current proposal makes extremely unlikely that a graduate entry route into pharmacy, which has been so successful in medicine, will be a meaningful option.
Consultation question 2: Do you agree with our proposal to continue providing public funding for students studying for a foundation degree as an equivalent or lower qualification (ELQ)?

This proposal makes no sense at all in the context of the failure to exempt important qualifications such as pharmacy that have a strong vocational focus.

Consultation question 3: Do you agree with our proposal to allow students studying for an ELQ to count towards the delivery of separately monitored co-funded additional student numbers (ASNs)?

This seems pragmatic and clearly sits comfortably with the employer engagement agenda. However, it must be recognised that the nature of some of the existing sophisticated and deep partnerships, for example with the NHS, cannot be quantified by the simple payment of fees. Particularly at the post-graduate level of pharmacist practitioner development, there are numerous examples of 'in-kind' contributions from the NHS, including the mentoring of junior pharmacists as well conventional face-to-face delivery using visiting lecturers and joint appointments.

Consultation question 4: Do you agree with the proposal to introduce an allocation for strategically important and vulnerable subjects (SIVS), calculated on the basis of ELQ numbers studying SIVS?

Yes. A number of SIV subjects feature prominently in the Pharmacy curriculum so the School of Pharmacy is keen to see that academic capacity in these subjects is maintained and developed. A number of the subjects, including medicinal, pharmaceutical chemistry and structural chemistry are crucial to drug discovery programmes. Moreover, pharmacists play important roles across the pharmaceutical industry. In 2005, UK pharmaceutical industry exports were approximately £12.2 billion, creating a surplus of £3.4 billion (source: Association of British Pharmaceutical Industry).

Consultation question 5: Do you agree that we should provide a supplement to the part-time targeted allocation?

Yes.

Consultation question 6: Do you agree with our proposal to provide 'safety net' funding to maintain each institution's grant at a comparable 2007-08 level in cash terms?
Yes.

Consultation question 7: Do you consider that the ELQ policy outlined in this document is likely to have a differential impact on students, depending on their gender, race, whether they have a disability, or any other extraneous factors? If so, how might this be mitigated?

It seems inevitable that those from minorities who have managed to acquire a qualification but then wish to re-skill for another vocation, such as pharmacy, will be least able to so and be hardest hit by these proposals. In 2006/07 some 40% of new registrants with the Royal Pharmaceutical Society of Great Britain were from ethnic minority backgrounds.

Consultation question 8: Do you have any further comments?


The ELQ proposals run completely counter to continuing professional development, life-long learning and skills development. It makes no sense (academic or otherwise) to bundle PG Certificates, Diplomas and Masters together as equivalent qualifications.

  • Within the NHS, the Agenda for Change career framework is based on escalating post-graduate qualifications (the KSF - Knowledge and Skills Framework).
  • Extensive use is made of PG Diploma and Masters qualifications in Pharmacy to support NHS workforce development and enable the delivery of important aspects of health policy.
  • There is a clear academic progression route and practitioners should not be denied the opportunity build up their qualifications.
    The context here is the development of the pharmacists clinical role and specialisation as envisaged in Our Health, Our Care, Our Say and Our NHS, Our Future. It is strongly recommended that these planned professional programmes be exempted from the proposals to withdraw funding for ELQ. They are clearly different from a selection of unrelated programmes being chosen by students at random.

<<<<<